76 results
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
with disease assessment by IRRC (data cut-off date: September 13, 2023); Median EFS: ITT population − 9.8 months (95% CI: 5.9, 12.9); CI, confidence … outcomes *Censoring new non-protocol anti-cancer therapies including SCT with disease assessment by IRRC (data cut-off date: September 13, 2023); BM, bone
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
were MRD negative at last assessment and median duration of response was not reached.
Patients continue to be enrolled into the Phase 1 ALLCAR19 … remission were MRD negative at last assessment and median duration of response was not reached.
Table of contents
Development Strategy for Adult ALL
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
become invalid. (vi) The Parties’ assessment of currently Applicable Law is that [***]. (c) Information and Assistance. Each Party shall, [***] following
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
for assessment. So that different phase and different views that are taken in terms of analyzing data and it really depends on the agency. But that's
8-K
EX-99.2
wnu30l
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
2g8u3u78a
13 Feb 24
Regulation FD Disclosure
4:06pm
8-K
EX-10.1
kyigyggh5yb
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
EX-4.7
96v47gr r0n0rj6jgydj
7 Feb 24
Automatic shelf registration
10:00pm
8-K
EX-99.1
wqk2bqgvnk71hkig fxw
11 Dec 23
Regulation FD Disclosure
8:31am
8-K
EX-99.2
56c1j siouobc7w
11 Dec 23
Regulation FD Disclosure
8:31am
10-Q
qf9l jhgmecpjik
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
8ay0l7pe
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
eqxa 117d
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
fnjlhllixtdkh
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
424B5
4rsrvkn
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
c36g8n
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K/A
EX-99.2
yk8n dfv1j
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.2
pi99kd
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
5tzudu3ux
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm